Marstacimab (TFPI) - Onderzoeksklasse Biosimilar
Gecertificeerd

Marstacimab (TFPI) - Onderzoeksklasse Biosimilar

Catalog #: 10-912
Maat: 0.1 mg

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100
Technische Documentatie

Technische Specificaties

Background

Marstacimab is fully human monoclonal antibody that binds to and neutralizes TPFI activity and is under development for treatment of hemophilia. Marstacimab is a laboratory-engineered monoclonal antibody designed to treat hemophilia A and B patients, with or without inhibitors. It works by blocking and effectively preventing TFPI from performing the anticoagulant function that it naturally carries out in the human body.

Immunogen

Homo sapiens / TFPI [Homo sapiens]

Clonality

• Recombinant Monoclonal

Conjugation

Unconjugated

Type

Primary Antibodies, Biosimilars

Source

CHO cells

Field of Research

Neuroscience

Purification

>95%

Concentration

Batch dependent

Buffer

PBS buffer pH7.5

Modification

None

Shipping Conditions

Blue Ice

Storage Conditions

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.

Fragment

IgG1-lambda

NCBI Organism

Homo sapiens

Other Product Names

PF-06741086

Beschrijving

Marstacimab (TFPI) - Onderzoeksklasse Biosimilar Beschikbaar in 0.1 mg. Bestel eenvoudig online met snelle levering.

Specificaties

ProductnaamMarstacimab (TFPI) - Onderzoeksklasse Biosimilar
Categorie
Beschikbare grootte0.1 mg
Catalogusnummer10-912